- Home
- AXSM vs KFY Comparison
AXSM vs KFY Comparison
Compare AXSM & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- KFY
- Stock Information
- Founded
- AXSM 2012
- KFY 1969
- Country
- AXSM United States
- KFY United States
- Employees
- AXSM N/A
- KFY N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- KFY Diversified Commercial Services
- Sector
- AXSM Health Care
- KFY Consumer Discretionary
- Exchange
- AXSM Nasdaq
- KFY Nasdaq
- Market Cap
- AXSM 5.9B
- KFY 3.6B
- IPO Year
- AXSM 2015
- KFY 1999
- Fundamental
- Price
- AXSM $130.24
- KFY $69.08
- Analyst Decision
- AXSM Strong Buy
- KFY Buy
- Analyst Count
- AXSM 19
- KFY 2
- Target Price
- AXSM $174.26
- KFY $80.00
- AVG Volume (30 Days)
- AXSM 439.8K
- KFY 414.3K
- Earning Date
- AXSM 11-03-2025
- KFY 12-04-2025
- Dividend Yield
- AXSM N/A
- KFY 2.81%
- EPS Growth
- AXSM N/A
- KFY 33.45
- EPS
- AXSM N/A
- KFY 4.69
- Revenue
- AXSM $495,033,000.00
- KFY $2,763,755,000.00
- Revenue This Year
- AXSM $63.62
- KFY $4.39
- Revenue Next Year
- AXSM $55.72
- KFY $4.42
- P/E Ratio
- AXSM N/A
- KFY $14.59
- Revenue Growth
- AXSM 69.83
- KFY 0.93
- 52 Week Low
- AXSM $75.56
- KFY $59.23
- 52 Week High
- AXSM $139.13
- KFY $80.64
- Technical
- Relative Strength Index (RSI)
- AXSM 65.37
- KFY 42.57
- Support Level
- AXSM $119.47
- KFY $67.93
- Resistance Level
- AXSM $130.81
- KFY $70.34
- Average True Range (ATR)
- AXSM 4.30
- KFY 1.45
- MACD
- AXSM 0.81
- KFY -0.06
- Stochastic Oscillator
- AXSM 76.32
- KFY 22.49
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.